Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. Research Outputs

Browsing by Author Yang W.-T.


Jump to:
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 81  next >
Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
2020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Liver Cancer
2020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; TUNG-HUNG SU ; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Liver Cancer
2020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; CHEN-HUA LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Liver Cancer
2020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; CHUN-JEN LIU ; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Liver Cancer
2020Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTseng T.-C.; Peng C.-Y.; Hsu Y.-C.; Su T.-H.; Wang C.-C.; Liu C.-J.; Yang H.-C.; Yang W.-T.; Lin C.-H.; Yu M.-L.; Lai H.-C.; Tanaka Y.; Nguyen M.H.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Liver Cancer
2021Evaluation of using WGS/WES to characterize ACMG actionable genes in genetic testing reportsYang W.-T.; Wu D.-C.; Liu J.-F.; Hong J.-B.; Wu J.-T.; PEI-LUNG CHEN ; Chen C.-Y.Proceedings - 2021 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2021
2017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO American Journal of Gastroenterology
2017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; Liu C.-J.; TUNG-HUNG SU ; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology
2017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; CHUN-JEN LIU ; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology
2017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology
2017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; CHEN-HUA LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology
2017Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular CarcinomaTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; CHI-LING CHEN ; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.American Journal of Gastroenterology
2018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Alimentary Pharmacology and Therapeutics
2018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; Liu C.-J.; TUNG-HUNG SU ; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics
2018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; CHUN-JEN LIU ; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics
2018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics
2018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Kuo S.F.-T.; CHEN-HUA LIU ; Chen P.-J.; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics
2018Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infectionTseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; CHI-LING CHEN ; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Alimentary Pharmacology and Therapeutics
2014Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTseng T.-C.; Liu C.-J.; Yang W.-T.; CHI-LING CHEN ; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)
2014Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconvertersTseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO Journal of Gastroenterology and Hepatology (Australia)
Showing results 1 to 20 of 81  next >

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback